Hi Jean/Ally, I am not considering it for myself. I am a researcher working to improve the quality of life of Parkinson’s disease patient. Apomorphine is given by subcutaneous injection to manage “off” episodes occurred during levodopa/carbidopa therapy. It is currently approved in Europe (ApoGo pen and ApoGo patch pump) and in US (Apokyn)
Report
There was a problem reporting this post.
Block Member?
Please confirm you want to block this member.
You will no longer be able to:
See blocked member's posts
Mention this member in posts
Invite this member to groups
Message this member
Add this member as a connection
Please note:
This action will also remove this member from your connections and send a report to the site admin.
Please allow a few minutes for this process to complete.